Jared Freedberg's most recent trade in Intercept Pharmaceuticals Inc was a trade of 771 Common Stock done at an average price of $10.5 . Disclosure was reported to the exchange on Aug. 1, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intercept Pharmaceuticals Inc | Jared Freedberg | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.50 per share. | 01 Aug 2023 | 771 | 57,214 (0%) | 0% | 10.5 | 8,096 | Common Stock |
| Intercept Pharmaceuticals Inc | Jared Freedberg | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.07 per share. | 01 May 2023 | 771 | 57,985 (0%) | 0% | 17.1 | 13,161 | Common Stock |
| Intercept Pharmaceuticals Inc | Jared Freedberg | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.76 per share. | 01 Feb 2023 | 918 | 58,756 (0%) | 0% | 18.8 | 17,222 | Common Stock |
| Intercept Pharmaceuticals Inc | Jared Freedberg | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 20,000 | 20,000 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Jared Freedberg | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 12,200 | 59,674 (0%) | 0% | 0 | Common Stock | |
| Intercept Pharmaceuticals Inc | Jared Freedberg | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.37 per share. | 31 Dec 2022 | 718 | 47,474 (0%) | 0% | 12.4 | 8,882 | Common Stock |
| Intercept Pharmaceuticals Inc | Jared Freedberg | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.73 per share. | 01 Nov 2022 | 771 | 48,192 (0%) | 0% | 15.7 | 12,128 | Common Stock |
| Intercept Pharmaceuticals Inc | Jared Freedberg | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.21 per share. | 01 Aug 2022 | 771 | 48,963 (0%) | 0% | 12.2 | 9,414 | Common Stock |
| Intercept Pharmaceuticals Inc | Jared Freedberg | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.71 per share. | 01 May 2022 | 771 | 49,734 (0%) | 0% | 15.7 | 12,112 | Common Stock |
| Intercept Pharmaceuticals Inc | Jared Freedberg | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.91 per share. | 01 Feb 2022 | 4,072 | 50,505 (0%) | 0% | 16.9 | 68,858 | Common Stock |
| Intercept Pharmaceuticals Inc | Jared Freedberg | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 17,600 | 17,600 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Jared Freedberg | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 10,300 | 54,577 (0%) | 0% | 0 | Common Stock |